doi: 10.1007/978-1-4757-0259-0_14.
Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial
- PMID: 6931477
- DOI: 10.1007/978-1-4757-0259-0_14
Item in Clipboard
Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia: update of an ongoing trial
Adv Exp Med Biol.
1980.
No abstract available
Similar articles
-
Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia.Blood. 1979 Sep;54(3):636-41. Blood. 1979. PMID: 288486 Clinical Trial.
-
Failure of lithium to reduce period of neutropenia during induction therapy of acute myeloid leukemia.Hematol Oncol. 1989 Jan-Feb;7(1):69-75. doi: 10.1002/hon.2900070108. Hematol Oncol. 1989. PMID: 2491829 Clinical Trial.
-
Failure of lithium to limit neutropenia significantly during induction therapy of acute myelogenous leukemia. A Southeastern Cancer Study Group study.Am J Clin Oncol. 1984 Aug;7(4):365-9. doi: 10.1097/00000421-198408000-00014. Am J Clin Oncol. 1984. PMID: 6430063 Clinical Trial.
-
Attenuation of chemotherapy-induced neutropenia with lithium carbonate.Am J Hosp Pharm. 1980 Aug;37(8):1066-71. Am J Hosp Pharm. 1980. PMID: 6996479 Review. No abstract available.
-
Antibacterial therapy--special considerations in neutropenic patients.Clin Haematol. 1976 Jun;5(2):347-60. Clin Haematol. 1976. PMID: 181192 Review. No abstract available.
Cited by
-
Identifying patients at risk for, and treatment of major psychiatric complications of cancer.Support Care Cancer. 1995 Jan;3(1):45-60. doi: 10.1007/BF00343921. Support Care Cancer. 1995. PMID: 7697303 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical